Seres Therapeutics (MCRB) Peer Comparison

$4.93

$0.17 (3.57%)

As on 27-Aug-2026 12:21EDT

Market cap

$46 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

1.3

Div. Yield

0 %

Edit

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Market cap ($ Mln)	46	16,614	17,326	13,400	12,305
Revenue ($ Mln)	2	1,054	2,782	2,436	670
Net Profit ($ Mln)	-22.46	755.85	491.50	860.62	-319.95
Net Margin (%)	-1,192.94	71.69	17.67	35.33	-47.79
RoE (%)	-57.05	--	110.09	42.98	-71.14
Price to Earnings	--	19.38	36.49	17.01	--
Price-To-Book	1.33	10.05	39.43	7.27	26.44

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Operating Revenue	1.88	1,054.37	2,782.29	2,435.92	669.50
Cost of Revenue	0.33	103.47	1,982.07	85.67	19.14
Gross Profit	-3.34	588.53	760.62	2,236.43	829.45
Operating Expenses	85.59	841.45	216.81	1,378.74	895.93
Operating Profit (EBIT)	-84.03	109.45	583.40	971.51	-226.44
Other Income	0.00	0.00	0.00	0.00	0.00
Profit before Tax	-22.46	101.11	598.92	1,035.47	-252.08
Provision for Tax	0.00	-654.74	107.42	174.84	20.05
Profit after Tax (Net Income)	-22.46	755.85	491.50	860.62	-319.95
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Consolidated Profit	0.00	0.00	0.00	0.00	0.00

Liabilities ($ Mln)

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Shareholder's Funds	34.53	1,435.90	433.86	1,843.76	465.53
Minority Interest	0.00	0.00	0.00	0.00	-47.83
Non-Current Liabilities	47.02	384.48	187.89	288.55	1,362.63
Current Liabilities	20.03	464.70	1,435.43	361.93	283.35
Total Liabilities	138.19	1,302.02	1,975.47	2,844.42	1,385.30

Assets ($ Mln)

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Non-Current Assets	59.24	895.24	1,006.90	1,243.41	440.60
Current Assets	42.35	1,389.84	1,050.29	1,250.82	1,671.41
Total Assets	138.19	1,302.02	1,975.47	2,844.42	1,385.30
Total Debt*	56.64	449.89	120.10	165.93	864.07
Net Current Assets	22.32	0.00	-385.14	888.90	1,388.07

Cashflow ($ Mln)

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Cash From Operating Activities	1.12	51.77	713.22	884.27	179.55
Cash Flow from Investing Activities	-0.04	-8.15	-31.14	350.44	-129.29
Cash from Financing Activities	13.90	34.89	-860.39	-969.59	74.01
Net Cash Inflow / Outflow	--	--	--	--	--

Ratios

Profitability Ratios

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
ROCE (%)	4.90	-30.01	53.56	32.82	-0.17
ROE (%)	-57.05	163.18	110.09	42.98	-71.14
ROA (%)	-15.16	26.53	15.64	29.32	-16.12
EBIT Margin (%)	-1,436.22	5.73	21.13	31.04	-0.77
Net Margin (%)	-1,192.94	71.69	17.67	35.33	-47.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

Growth Ratios

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Revenue Growth (%)	-68.40	114.85	24.67	9.23	12.22
EBIT Growth (%)	49.77	136.39	18.70	-3.99	93.17
Net Profit Growth (%)	-126.13	378.76	17.50	42.89	-115.58
EPS Growth (%)	-121.20	353.27	26.84	50.42	-73.87
Book Value Growth (%)	-4.98	816.12	164.02	-0.70	-13.57

Valuation Ratios

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Price / Earnings	23.17	-59.76	36.06	15.79	-2,869.63
Price / Book Value	2.98	-80.42	35.44	5.72	10.04
Dividend Yield (%)	--	--	--	--	--
EV/EBITDA	17.21	-121.54	28.08	12.44	25.04
Market Cap ($ Cr)	--	--	--	--	--

Solvency Ratios

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debt to Equity	0.00	0.00	0.00	0.00	1.77
Short term debt to equity ratio	0.34	0.05	0.00	0.00	0.09
Current Ratio	2.11	2.99	0.73	3.46	5.90
Quick Ratio	2.11	2.32	0.73	3.38	5.90
Interest Coverage	--	1.62	--	--	-1.72

Operating Efficiency Ratios

	Seres Therapeutics (MCRB)	Ascendis Pharma A/S - ADR	Medpace Holdings (MEDP)	Exelixis (EXEL)	Arrowhead Pharmaceuticals (ARWR)
Debtors to sales (%)	1,342.22	21.25	15.88	13.74	1.28
Asset Turnover	0.01	0.37	0.89	0.83	0.34
Receivable days	1,183.01	85.52	50.42	43.48	1.50
Inventory Days	--	1,056.70	--	96.17	--
Payable days	254.56	331.01	6.26	147.97	221.81
Cash Conversion Cycle	--	811.21	--	-8.32	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly